Neurogene Inc. (NASDAQ: NGNE)
$45.74
-0.2100 ( -0.46% ) 90.0K
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.
Market Data
Open
$45.74
Previous close
$45.95
Volume
90.0K
Market cap
$593.85M
Day range
$44.25 - $47.31
52 week range
$12.49 - $53.00
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 12 | Dec 06, 2023 |
| 8-k | 8K-related | 13 | Dec 04, 2023 |
| 10-q | Quarterly Reports | 51 | Nov 14, 2023 |
| 4 | Insider transactions | 1 | Oct 10, 2023 |
| 8-k | 8K-related | 16 | Sep 22, 2023 |
| 4 | Insider transactions | 1 | Aug 17, 2023 |
| 4 | Insider transactions | 1 | Aug 14, 2023 |
| 10-q | Quarterly Reports | 53 | Aug 10, 2023 |
| 8-k | 8K-related | 55 | Jul 18, 2023 |